Sulfonamide Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2029
Sulfonamide Market: Introduction
Sulfonamide is a functional group used in various drug formulation which is commonly known as sulpha drugs or sulfa drugs. It is among the first antimicrobial drug used in the treatment of bacterial infections in animals and humans. Sulfonamides act as antimetabolites which block purine and pyrimidine biosynthesis during the synthesis of folic acid, thereby inhibiting bacterial infection. Rising awareness on preventing disease, growing demand for functional food and increasing prevalence of the infectious disease worldwide drive the growth of sulfonamide market. Also, an increase in healthcare expenditure and increasing awareness about health-consciousness results in the growth of the global sulfonamide market and is projected to open new opportunities for the sulfonamide market in the coming future. The global market for sulfonamide is estimated to witness a healthy CAGR during the forecast period of 2020 to 2030.
Sulfonamide Market: Market Dynamics
Increased usage of sulfonamide in treating infectious diseases and the rising popularity of functional food is the key factor augmenting the growth of sulfonamide market globally. Sulfonamide is commonly used in the treatment and prevention of numerous diseases such as bacterial infection, diabetes, HIV AIDS, urinary tract infection, and many more. Thus, an increase in the frequency of chronic disorders worldwide and increasing aging population leads to an increased sulfonamide consumption. Moreover, the ease of availability of various sulfonamide drugs at a reasonable price further contributes to the growth of the global sulfonamides market. Besides, growing R&D activities and government funding in healthcare sector results in the development of innovative and better-quality sulfonamides with enhanced therapeutic activity which further fuels the growth of global sulfonamide market over the forecast period. In addition, rapid development of sulfonamide based dietary supplements is likely to boost the growth of global sulfonamide market. However, side effects associated with sulfonamides such as dizziness, diarrhea, hypersensitivity, kernicterus, and nausea or vomiting and presence of potential substitutes with minor side effects such as macrolides, quinolones are likely to affect the growth of the global sulfonamides market.
Sulfonamide Market: Segmentation
Based on the function, the sulfonamide market is segmented as:
Based on the type, the sulfonamide market is segmented as:
Sulfonamide Market: Regional Outlook
Global sulfonamide market is divided into six regions including North America, Latin America, Europe, East Asia, South Asia & Oceania, and Middle East & Africa (MEA). Among the regions mentioned above, sulfonamide is most commonly used in developing countries such as China, India, and ASEAN countries owing to its low prices and ease of availability. China and India with the largest population pool globally have witnessed a high frequency of diseased and infectious people resulting in the growth of sulfonamide consumption. In contrast, the usage of sulfonamide in developed countries has witnessed a downfall due to the seldom appear of sulfonamide in doctor’s prescription and growing awareness about the side effects of sulfonamide. North America is expected to witness steady growth over the forecast period due to growing awareness concerning sulfa drugs, well-developed healthcare infrastructure and presence of harmonized regulatory structure. Europe is likely to witness a similar trend as North America, with moderate growth over the coming years. Latin America is anticipated to grow higher than the global average growth leveraging the low-cost benefits of sulfonamide.
Sulfonamide Market: Market stakeholders
Key market stakeholders in the global sulfonamide market are Boehringer Ingelheim Pharmaceuticals, Abbott Laboratories, GlaxoSmithKline plc, Bayer AG, King Pharmaceuticals, Novartis International AG, Mylan Pharmaceuticals, Teva Pharmaceuticals, Stiefel Laboratories, Roche Holding AG, Sanofi Aventis, Par Pharmaceutical and Pfizer. Bayer AG was the first company to experiment with Prontosil in 1932. The sulfonamide market consists of well-diversified global and regional players with the global vendors ruling the market.
The research report presents a comprehensive assessment of the sulfonamide market and contains thoughtful insights, facts, historical data and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The sulfonamide market report provides analysis and information, according to market segments such as geographies, applications and types.
Sulfonamide Market Report Covers Exhaustive Analysis On:
The sulfonamide report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The Sulfonamide report provides an in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The sulfonamide report also maps the qualitative impact of various market factors on market segments and geographies.
Sulfonamide Market Report Highlights:
The study presents a granular assessment and quantitative evaluation of:
The region-wise assessment includes market dynamics in:
The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.
The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:
Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.
Flat 10% discount on Single User License if you prebook this report
Flat 10% discount on Multiple User License if you prebook this report
Flat 10% discount on Corporate License if you prebook this report